4 completed, 1 unknown. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Unknown 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow SMT: new trials by email Literature Review of SMT trials Research Report on SMT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19 Prolastin, Standard Medical Treatment - COVID-19 | Phase 2 | Completed | Instituto Grifols, S.A. | 100 | 2020-07-29 | 2021-07-08 |
| Optimization of Spinal Manipulative Therapy Protocols SMT, Mobilizing Exercises, Activation Exercises - Low Back Pain | Phase 2 | Completed | University of Utah | 273 | 2017-02-22 | 2023-05-17 |
| Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus GLP-1, SC, Standard Medical Treatment - Type 2 Diabetes | Phase 1 / Phase 2 | Unknown | Diabetes Care Center of Nanjing Military Command | 100 | 2013-10-01 | 2014-02-20 |
| Pregnancy-Related Low Back Pain and Complementary and Alternative Medicine (CAM) Treatment Exercise, Spinal Manipulation, Neuroemotional Technique (NET) - Low Back Pain | Phase 2 | Completed | Oregon Health and Science University | 64 | 2009-07-01 | 2019-12-18 |
| Bone Marrow Mononuclear Cell and Hyperbaric Oxygen Therapy in Diabetes Mellitus BM-MNC+HOT, BM-MNC, HOT - Type 2 Diabetes Mellitus | Phase 1 / Phase 2 | Completed | Fuzhou General Hospital | 82 | 2008-03-01 | 2017-09-21 |
Diabetes Mellitus, Type 2 (2) · Low Back Pain (2) · Motor Activity (2) · COVID-19 (1) · Pain (1)
Diabetes Care Center of Nanjing Military Command (1) · Fuzhou General Hospital (1) · Instituto Grifols, S.A. (1) · Oregon Health and Science University (1) · University of Utah (1)
China (2) · United States (2) · Canada (1) · Spain (1)
Jianming Tan, professor (1) · Julie M Fritz, PhD, PT (1) · Thomas Gregory, MD (1) · Xiangjin Xu, Professor (1)
PMID 22694756, PMID 24290656, PMID 25559146, PMID 27143183, PMID 29866131